This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.
In your application messsage, please share your background and what you can contribute to the group.
Company Overview and News
GATX Corporation (GATX - Free Report) performed impressively in the second quarter of 2018, reporting better-than-expected earnings per share and revenues. The company’s earnings (excluding 15 cents from non-recurring items) of $1.16 per share surpassed the Zacks Consensus Estimate of 92 cents. However, the bottom line decreased 12.1% year over year due to higher costs. Expenses pertaining to the closure of a railcar maintenance facility in Germany weighed on the bottom line in the quarter under review.
GATX KDP AAL JBLU GMTA NSC GMT
Global equity markets continued to advance. Last week's newsletter noted the importance of closing the week above the all-important 2750 level in the EMINI SP500 Sept contract. We knew this level was huge, considering the close below on June 29th sent the contract below our 7-week moving average and was on the cusp of losing further ground. But all tariff worries aside, all geopolitical NATO posturing aside, the equity markets continued their advance on the tailwinds of massive continued corporate buybacks.
WFCNP WFC.PRL WFC.PRJ WFC.PRT WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN AVGO WFC.PRY WFC.PRX WFC.PRW WFC.PRV WFC WFC.WS C AAL PNC.PRP PNC.PRQ PNCFO CAIAF CA PNC.WS JPM PNC PNUCL BRCM PZZA
In the past week, Delta Air Lines, Inc. (DAL - Free Report) kick-started the second-quarter earnings season for the airline space. This Atlanta, GA-based carrier reported better-than-expected revenues and earnings per share. However, Delta trimmed its projection for current-year earnings per share citing high fuel costs.
AAL HA JBLU SAVE UAL DAL
(Reuters) - United Airlines (UAL.N) raised its profit forecast for 2018 on Tuesday, breaking a trend for U.S. airlines as average fares and traffic both rose and it trimmed capacity expansion in the face of soaring fuel costs.
REUTERS: United Airlines raised its profit forecast for 2018 on Tuesday, breaking a trend for U.S. airlines as average fares and traffic both rose and it trimmed capacity expansion in the face of soaring fuel costs.
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
FDP AAL SBUX 9984 SFTBF SFTBY
From the age of 25–40, my range of emotions could generously be described as “narrow.” I loved nobody, and the only real emotions I felt were satisfaction or disappointment from my ambition as I howled in the money storm. My approach to life could best be summarized as “I want more, f***ing more.” Problem is, “more” started getting harder to define. During that 15-year period, I laughed out loud a lot less than before and didn’t cry once.
FB TM AAL TWX JBLU NFLX SAVE GOOG UAL TWC AMZN T GOOGL VZ DAL DIS
Airlines stocks have been losing altitude lately. Because they have great cash-flow generation and several return a large amount of capital, though, some investors are no doubt wondering if now’s the time to buy. There are a number of different names, but for this article, I wanted to take a look at the largest in the industry.
BRK.A F GM.WS.A AAL GM.WS.B GM.WS.C GM UAL GM.WSB DAL LUV
The startup has told its 6,000 global workers that they will no longer be able to expense meals including meat, and that it won’t pay for any red meat, poultry or pork at WeWork events. In an email to employees this week outlining the new policy, co-founder Miguel McKelvey said the firm’s upcoming internal Summer Camp retreat would offer no meat options for attendees.
FDP AAL 9984 SFTBF SFTBY
"The greatest shortcoming of the human race is our inability to understand the exponential function." -Albert Bartlett
LBRDB LSXMB BATRK FWONB AAL LSXMA BATRR LBRDK FWONA VA AN CHTR FWONK BATRB LSXMK LBRDA DAL BATRA TIVO
Average Annual Total Returns (06/30/18) Since Inception (08/05/91) 12.84% 10–year 12.48% 5–year 13.07% 1–year 13.46% 3–month 2.13% Gross Expense Ratio as of 09/30/17 was 0.90% Net Expense Ratio as of 09/30/17 was 0.86%
MGM APC FB BMYMP AAL ADP MA NFLX HOG IT V AFL ADPVV AAPL HLT AEUA BMY
July 12, 2018: Here are four stocks trading with heavy volume among 63 equities making new 52-week lows in Thursday’s session. On the NYSE advancers led decliners by about 1.53 to 1 and on the Nasdaq, advancers led decliners by about 1.42 to 1.
AAL AVGO HK AVP BRCM
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
AAL SAVE DAL
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
Silicon Investor Message Boards
This table lists all message boards related to AAL / American Airlines Group Inc. on message board site Silicon Investor.
|American Airlines Group, Inc.||AaLs u0026 Carps|
|VAALCO Energy, Inc.||AMERALIA, INC. (AALA)|
|Advanced Logic Research (AALR)|
as of ET